Response to Kang et al
J Natl Cancer Inst
.
2023 Oct 9;115(10):1234-1235.
doi: 10.1093/jnci/djad166.
Authors
Carlos A Garcia-Prieto
1
2
,
Veronica Davalos
1
,
Manel Esteller
1
3
4
5
Affiliations
1
Cancer and Leukemia Epigenetics and Biology Program (PEBCL), Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
2
Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain.
3
Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.
4
Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
5
Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.
PMID:
37594781
DOI:
10.1093/jnci/djad166
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
Grants and funding
Generalitat de Catalunya for institutional
AEI/10.13039/501100011033//MCIN
European Development Regional Fund
PID2021-125282OB-I00/Europe" ERDF
Departament de Recerca i Universitats
2021 SGR 01494/Generalitat de Catalunya